Hideomi Kijima

Title: Innovations of Hideomi Kijima

Introduction

Hideomi Kijima is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of three patents to his name, Kijima's work focuses on compounds that have therapeutic applications.

Latest Patents

Kijima's latest patents include a salt and crystal form of a compound that exhibits agonistic activity to the S1P5 receptor. This compound, referred to as Compound I, demonstrates high selectivity for the S1P receptor and is presented as a drug substance for pharmaceuticals. Another significant patent involves an ethane-sulfonate salt of a quinoline derivative. This invention relates to a compound that has Axl-inhibiting activity, making it useful as a prophylactic and therapeutic agent for immune diseases and cancer.

Career Highlights

Throughout his career, Kijima has worked with prominent companies in the pharmaceutical industry, including Ono Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas.

Collaborations

Kijima has collaborated with notable colleagues such as Shizuka Ono and Takahiro Nekado. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Hideomi Kijima's contributions to pharmaceutical innovations highlight his expertise and dedication to improving therapeutic options. His patents reflect a commitment to addressing significant health challenges through scientific advancements.